Literature DB >> 1720924

Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland.

J G Donahue1, K E Nelson, A Muñoz, D Vlahov, L L Rennie, E L Taylor, A J Saah, S Cohn, N J Odaka, H Farzadegan.   

Abstract

In order to define the risk factors for infection with hepatitis C virus, the authors determined the prevalence and incidence of antibodies to hepatitis C in three cohorts in Baltimore, Maryland, enrolled in prospective studies of human immunodeficiency virus (HIV-1) infection. Among 500 multi-transfused patients who underwent cardiac surgery in 1985 and 1986, 12 (2.4%) were hepatitis C seropositive before surgery while 19 (3.9%) developed antibodies in the 8-12 months after surgery. The seroprevalence of hepatitis C virus among 225 intravenous drug users followed since 1988 was 85%, which did not vary by HIV-1 status. Longer duration of intravenous drug use was significantly associated with hepatitis C seropositivity. Among 926 homosexual/bisexual men followed since 1984, 15 (1.6%) were hepatitis C seropositive; only intravenous drug use and a history of hepatitis A were marginally associated with hepatitis C in this population. No association was found between hepatitis C virus and HIV-1 or sexual behavior variables in this population. These data suggest that hepatitis C is readily transmitted by blood exposure, but is transmitted inefficiently by sexual means.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720924     DOI: 10.1093/oxfordjournals.aje.a116023

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.

Authors:  N J Bodsworth; P Cunningham; J Kaldor; B Donovan
Journal:  Genitourin Med       Date:  1996-04

3.  Health conditions among aging narcotics addicts: medical examination results.

Authors:  Yih-Ing Hser; Lillian Gelberg; Valerie Hoffman; Christine E Grella; William McCarthy; M Douglas Anglin
Journal:  J Behav Med       Date:  2004-12

4.  HCV status knowledge and risk behaviours amongst intravenous drug users.

Authors:  G Vidal-Trécan; J Coste; I Varescon-Pousson; B Christoforov; A Boissonnas
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

5.  Clinical sequelae of hepatitis C acquired from injection drug use.

Authors:  M J Tong; N S el-Farra
Journal:  West J Med       Date:  1996-05

Review 6.  Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

Authors:  R Heimer
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

7.  Hepatitis virus infection and liver disease in injecting drug users who died suddenly.

Authors:  E A McCruden; K J Hillan; I C McKay; M T Cassidy; J C Clark
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

8.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

Authors:  I van Beek; R Dwyer; G J Dore; K Luo; J M Kaldor
Journal:  BMJ       Date:  1998-08-15

9.  Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland.

Authors:  D Vlahov; K E Nelson; T C Quinn; N Kendig
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

10.  The epidemiology of hepatitis C in Turkey.

Authors:  D L Thomas; R W Mahley; S Badur; E Palaoglu; T C Quinn
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.